Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT

被引:51
作者
Giesel, Frederik L. [1 ,2 ,3 ]
Will, Leon [1 ]
Kesch, Claudia [4 ]
Freitag, Martin [2 ,5 ]
Kremer, Christophe [1 ]
Merkle, Jonas [1 ]
Neels, Oliver C. [6 ]
Cardinale, Jens [6 ]
Hadaschik, Boris [4 ]
Hohenfellner, Markus [4 ]
Kopka, Klaus [6 ]
Haberkorn, Uwe [1 ,2 ]
Kratochwil, Clemens [1 ]
机构
[1] Univ Hosp Heidelberg, Dept Nucl Med, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Cooperat Unit Nucl Med, Heidelberg, Germany
[3] German Canc Consortium DKTK, Heidelberg, Germany
[4] Univ Hosp Heidelberg, Dept Urol, Heidelberg, Germany
[5] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany
[6] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
关键词
peptides; PET/CT; biochemical recurrence; F-18-PSMA-1007; PSMA-PET; prostate cancer; POSITRON-EMISSION-TOMOGRAPHY; GA-68-LABELED PSMA LIGAND; RADICAL PROSTATECTOMY; RADIATION-DOSIMETRY; MEMBRANE ANTIGEN; BIODISTRIBUTION; DIAGNOSIS; PET/MRI;
D O I
10.2967/jnumed.117.196329
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Biochemical recurrence (BCR) is a concern for prostate cancer patients after local treatment. Ga-68-labeled prostate-specific membrane antigen (PSMA) ligands have significantly improved prostate cancer imaging. However, several F-18-labeled ligands that were developed as fluorinated tracers might present advantages. In this study, we analyzed the potential of F-18-PSMA-1007 in patients with BCR. Methods: Twelve patients with BCR after local treatment underwent PET/CT scans 1 and 3 h after injection of F-18-PSMA-1007. Results: F-18-PSMA-1007 PET/CT detected lesions in 9 of 12 patients (75%). A significant difference was observed when comparing the tracer uptake in F-18-PSMA-1007-positive lesions 1 and 3 h after injection (median SUVmax, 7.00 vs. 11.34; P < 0.001; n = 76). Forty-four (88%) of 50 F-18-PSMA-1007-positive lymph nodes had a short-axis diameter of less than 8 mm. Conclusion: In this pilot study, F-18-PSMA-1007 PET/CT presented high potential for localization of recurrent disease in prostate cancer patients with BCR.
引用
收藏
页码:632 / 635
页数:4
相关论文
共 19 条
  • [1] Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
    Afshar-Oromieh, A.
    Haberkorn, U.
    Schlemmer, H. P.
    Fenchel, M.
    Eder, M.
    Eisenhut, M.
    Hadaschik, B. A.
    Kopp-Schneider, A.
    Roethke, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 887 - 897
  • [2] Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    Afshar-Oromieh, Ali
    Holland-Letz, Tim
    Giesel, Frederik L.
    Kratochwil, Clemens
    Mier, Walter
    Haufe, Sabine
    Debus, Nils
    Eder, Matthias
    Eisenhut, Michael
    Schaefer, Martin
    Neels, Oliver
    Hohenfellner, Markus
    Kopka, Klaus
    Kauczor, Hans-Ulrich
    Debus, Juergen
    Haberkorn, Uwe
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (08) : 1258 - 1268
  • [3] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    Afshar-Oromieh, Ali
    Avtzi, Eleni
    Giesel, Frederik L.
    Holland-Letz, Tim
    Linhart, Heinz G.
    Eder, Matthias
    Eisenhut, Michael
    Boxler, Silvan
    Hadaschik, Boris A.
    Kratochwil, Clemens
    Weichert, Wilko
    Kopka, Klaus
    Debus, Juergen
    Haberkorn, Uwe
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 197 - 209
  • [4] [Anonymous], J NUCL MED MOL IMAGI
  • [5] Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
    Cho, Steve Y.
    Gage, Kenneth L.
    Mease, Ronnie C.
    Senthamizhchelvan, Srinivasan
    Holt, Daniel P.
    Jeffrey-Kwanisai, Akimosa
    Endres, Christopher J.
    Dannals, Robert F.
    Sgouros, George
    Lodge, Martin
    Eisenberger, Mario A.
    Rodriguez, Ronald
    Carducci, Michael A.
    Rojas, Camilo
    Slusher, Barbara S.
    Kozikowski, Alan P.
    Pomper, Martin G.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (12) : 1883 - 1891
  • [6] PSA-Stratified Performance of 18F- and 68Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer
    Dietlein, Felix
    Kobe, Carsten
    Neubauer, Stephan
    Schmidt, Matthias
    Stockter, Simone
    Fischer, Thomas
    Schomaecker, Klaus
    Heidenreich, Axel
    Zlatopolskiy, Boris D.
    Neumaier, Bernd
    Drzezga, Alexander
    Dietlein, Markus
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (06) : 947 - 952
  • [7] Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
    Eiber, Matthias
    Weirich, Gregor
    Holzapfel, Konstantin
    Souvatzoglou, Michael
    Haller, Bernhard
    Rauscher, Isabel
    Beer, Ambros J.
    Wester, Hans-Juergen
    Gschwend, Juergen
    Schwaiger, Markus
    Maurer, Tobias
    [J]. EUROPEAN UROLOGY, 2016, 70 (05) : 829 - 836
  • [8] Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
    Eiber, Matthias
    Maurer, Tobias
    Souvatzoglou, Michael
    Beer, Ambros J.
    Ruffani, Alexander
    Haller, Bernhard
    Graner, Frank-Philipp
    Kuebler, Hubert
    Haberhorn, Uwe
    Eisenhut, Michael
    Wester, Hans-Juergen
    Gschwend, Juergen E.
    Schwaiger, Markus
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) : 668 - 674
  • [9] Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI
    Freitag, Martin T.
    Radtke, Jan P.
    Afshar-Oromieh, Ali
    Roethke, Matthias C.
    Hadaschik, Boris A.
    Gleave, Martin
    Bonekamp, David
    Kopka, Klaus
    Eder, Matthias
    Heusser, Thorsten
    Kachelriess, Marc
    Wieczorek, Kathrin
    Sachpekidis, Christos
    Flechsig, Paul
    Giesel, Frederik
    Hohenfellner, Markus
    Haberkorn, Uwe
    Schlemmer, Heinz-Peter
    Dimitrakopoulou-Strauss, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (05) : 776 - 787
  • [10] 18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer
    Giesel, Frederik L.
    Kesch, Claudia
    Yun, Mijin
    Cardinale, Jens
    Haberkorn, Uwe
    Kopka, Klaus
    Kratochwil, Clemens
    Hadaschik, Boris A.
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E497 - E499